Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury.

scientific article published in July 2006

Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/NEU.2006.23.1111
P698PubMed publication ID16866624

P50authorJoong Woo LeemQ62132564
P2093author name stringClaire E Hulsebosch
Young Seob Gwak
Taick Sang Nam
Kwang Se Paik
Huai Yu Tan
P433issue7
P921main subjectchronic painQ1088113
neuropathic painQ2798704
chronic neuropathic painQ58490835
P304page(s)1111-1124
P577publication date2006-07-01
P1433published inJournal of NeurotraumaQ15716774
P1476titleActivation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury
P478volume23

Reverse relations

cites work (P2860)
Q39177497Analgesic Effect of Recombinant GABAergic Cells in a Model of Peripheral Neuropathic Pain.
Q39309945Baclofen as an adjuvant analgesic for cancer pain
Q43075742Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.
Q46351844Bilateral hyperexcitability of thalamic VPL neurons following unilateral spinal injury in rats.
Q36635432Cell transplantation for spinal cord injury: a systematic review
Q37115250Cingulate GABA levels inversely correlate with the intensity of ongoing chronic knee osteoarthritis pain
Q42548830Combination Drug Therapy for Pain following Chronic Spinal Cord Injury
Q37448404Conditional gene deletion reveals functional redundancy of GABAB receptors in peripheral nociceptors in vivo
Q38727831Current and Future Issues in the Development of Spinal Agents for the Management of Pain
Q42776669Effect of intrathecal glycine and related amino acids on the allodynia and hyperalgesic action of strychnine or bicuculline in mice
Q46320408Effects of Etanercept and Minocycline in a rat model of spinal cord injury
Q60053955Ethanol-induced enhancement of inhibitory synaptic transmission in the rat spinal substantia gelatinosa
Q37826940GABA and central neuropathic pain following spinal cord injury
Q38188497GABA pharmacology: the search for analgesics.
Q48324396How is chronic pain related to sympathetic dysfunction and autonomic dysreflexia following spinal cord injury?
Q53666755Inhibition of α5 subunit-containing GABAA receptors facilitated spinal nociceptive transmission and plasticity.
Q35803351Intraspinal transplantation of GABAergic neural progenitors attenuates neuropathic pain in rats: a pharmacologic and neurophysiological evaluation
Q38832495Intrathecal Transplantation of Embryonic Stem Cell-Derived Spinal GABAergic Neural Precursor Cells Attenuates Neuropathic Pain in a Spinal Cord Injury Rat Model.
Q37612317Intrathecal administration of GABA agonists in the vegetative state
Q37851908Ion channel blockers and spinal cord injury
Q37139432Locomotor dysfunction and pain: the scylla and charybdis of fiber sprouting after spinal cord injury
Q34081579Loss of central inhibition: implications for behavioral hypersensitivity after contusive spinal cord injury in rats.
Q36096233Modulation of Spinal GABAergic Inhibition and Mechanical Hypersensitivity following Chronic Compression of Dorsal Root Ganglion in the Rat.
Q51167310Neonatal bladder inflammation induces long-term visceral pain and altered responses of spinal neurons in adult rats.
Q39267599Neurobiological Effects of Morphine after Spinal Cord Injury
Q37851055Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury
Q41689858Neuronal-Glial Interactions Maintain Chronic Neuropathic Pain after Spinal Cord Injury.
Q38247950Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms
Q42080553Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury
Q35948021Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines
Q30357529Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.
Q43135694Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat.
Q51712501Rapamycin suppresses microglial activation and reduces the development of neuropathic pain after spinal cord injury.
Q37078246Recombinant neural progenitor transplants in the spinal dorsal horn alleviate chronic central neuropathic pain
Q34421188Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat
Q38318458Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches
Q33897359Spinal cord transection-induced allodynia in rats--behavioral, physiopathological and pharmacological characterization
Q47648437The H-Reflex as a Biomarker for Spinal Disinhibition in Painful Diabetic Neuropathy.
Q35852049The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy
Q37065365Validity of acute and chronic tactile sensory testing after spinal cord injury in rats
Q89634678Viral Vector-Mediated Gene Transfer of Glutamic Acid Decarboxylase for Chronic Pain Treatment: A Literature Review
Q48208357mir-500-Mediated GAD67 Downregulation Contributes to Neuropathic Pain.

Search more.